Medical Ultrasound Devices Market Size, Share, Growth, and Industry Analysis, By Type (Diagnostic Ultrasound Systems,Therapeutic Ultrasound Systems,), By Application (Radiology/General Imaging,Obstetrics/Gynecology,Cardiology,Urology,Vascular,Others,), Regional Insights and Forecast to 2035

Medical Ultrasound Devices Market Overview

The global Medical Ultrasound Devices Market size is projected to grow from USD 7285.95 million in 2026 to USD 7692.94 million in 2027, reaching USD 11891.27 million by 2035, expanding at a CAGR of 5.59% during the forecast period.

The global medical ultrasound devices market has been witnessing strong expansion due to the increasing prevalence of chronic diseases, rising maternal health awareness, and the growing geriatric population. More than 45% of imaging procedures in hospitals worldwide involve ultrasound equipment, with diagnostic ultrasound systems accounting for a significant proportion of usage. Over 70 million ultrasound scans are performed annually in Europe, and more than 60,000 ultrasound units are installed across hospitals in the United States, showcasing the market’s wide penetration.

Asia-Pacific is a growing hub, with China producing over 40% of ultrasound equipment exports globally. The Indian market alone records over 12,000 new installations every year, fueled by government investments in maternal healthcare programs. The demand for portable ultrasound devices has also increased sharply, with point-of-care ultrasound adoption growing by 25% annually in emergency medicine departments.

Technological advancements have significantly shaped the industry. AI-powered imaging platforms now support over 55% of high-end ultrasound devices launched since 2022, while 3D and 4D imaging technologies are used in over 65% of gynecology-related ultrasound examinations. The widespread adoption of handheld ultrasound devices has allowed clinicians to perform over 20% of diagnostic scans outside hospital settings, which is a notable shift in care delivery.

The USA medical ultrasound devices market is one of the most advanced globally, supported by rapid adoption of portable devices and a highly developed healthcare infrastructure. The country has more than 6,000 hospitals, with nearly 95% equipped with advanced ultrasound imaging systems. On average, over 28 million ultrasound procedures are performed annually in the USA, covering cardiology, obstetrics, and musculoskeletal imaging.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Over 62% of demand arises from diagnostic imaging procedures, highlighting ultrasound’s dominant role in global medical imaging applications.
• Major Market Restraint: Nearly 41% of facilities report cost barriers, limiting adoption of high-end ultrasound systems in low-resource healthcare settings globally.
• Emerging Trends: More than 55% of newly launched ultrasound devices feature AI-based platforms, driving faster diagnostics and improved accuracy across multiple clinical specialties.
• Regional Leadership: North America maintains 37% global share, with advanced installations across hospitals, strong prenatal imaging adoption, and rising point-of-care ultrasound usage.
• Competitive Landscape: Top five manufacturers control 52% of the market, with ongoing investments in innovation, AI integration, and portable ultrasound solutions dominating competition.
• Market Segmentation: Diagnostic ultrasound systems account for 72% of installations worldwide, with therapeutic ultrasound growing steadily across oncology, physiotherapy, and drug delivery applications.
• Recent Development: Over 47% of new ultrasound devices launched between 2023–2025 were portable, emphasizing rising demand for compact imaging solutions globally.

Medical Ultrasound Devices Market Latest Trends

The medical ultrasound devices market is undergoing significant transformation, with technological innovation and portability driving adoption. Portable and handheld ultrasound systems now account for over 34% of new installations, compared with only 12% five years ago. Advanced imaging modalities such as 3D, 4D, and Doppler technologies are now utilized in more than 70% of cardiovascular and gynecology scans, enhancing diagnostic precision.

AI-driven imaging platforms have surged, with more than 50% of premium ultrasound devices introduced after 2023 incorporating AI-based diagnostic assistance. The expansion of point-of-care ultrasound has been notable, with over 27% of emergency rooms across Europe and the USA now using handheld ultrasound systems. The rise in chronic disease prevalence has also fueled demand, as nearly 18 million cancer patients annually undergo ultrasound imaging as part of treatment monitoring.

Medical Ultrasound Devices Market Dynamics

DRIVER

"Rising demand for non-invasive diagnostic procedures"

The global increase in demand for non-invasive and radiation-free imaging is a key driver for ultrasound devices. More than 75% of obstetric procedures worldwide use ultrasound as the primary imaging tool due to safety and precision. Cardiology applications have also expanded, with echocardiography accounting for over 20% of total ultrasound procedures globally. As populations age, the demand for imaging related to vascular and urological disorders has risen, with nearly 28% of patients above 65 years undergoing ultrasound diagnostics annually.

RESTRAINT

"High cost of advanced ultrasound systems"

A major restraint is the high acquisition and maintenance costs of high-end ultrasound machines. More than 40% of small and mid-sized healthcare centers in Asia and Africa delay procurement due to limited budgets. Advanced 3D/4D ultrasound machines can cost significantly more than standard models, restricting adoption. Furthermore, over 36% of facilities worldwide report difficulties in upgrading to AI-based platforms because of both cost and training challenges.

OPPORTUNITY

"Growth in portable and point-of-care ultrasound"

The rising demand for portable and handheld ultrasound devices presents strong opportunities. Handheld systems have recorded over 25% growth annually in usage, particularly in rural and resource-limited regions. In developing economies, over 50% of maternal health programs now rely on portable ultrasound scanners for prenatal care. These devices are also expanding into home healthcare, with adoption increasing by 18% between 2022 and 2024 across private practices and diagnostic clinics.

CHALLENGE

"Shortage of skilled professionals"

A significant challenge lies in the shortage of skilled sonographers and radiologists. More than 30% of ultrasound scans globally face delays due to workforce shortages, particularly in developing nations. The World Health Organization highlights that regions in Sub-Saharan Africa and Southeast Asia have fewer than 2 radiologists per 100,000 people, limiting ultrasound utilization. Training requirements for AI-powered devices also pose challenges, with over 27% of hospitals reporting extended onboarding periods for staff.

Medical Ultrasound Devices Market Segmentation

The medical ultrasound devices market segmentation highlights strong dominance of diagnostic ultrasound systems, increasing adoption of therapeutic ultrasound, and diverse applications spanning radiology, obstetrics, cardiology, urology, vascular imaging, and emerging medical specialties globally.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Diagnostic Ultrasound Systems: Diagnostic ultrasound systems dominate worldwide installations, representing more than 72% of the market. They are widely utilized in radiology, cardiology, and obstetrics, with over 22 million cardiovascular scans annually performed using these systems. Hospitals and diagnostic centers across developed nations heavily rely on these devices for imaging.

Diagnostic ultrasound systems will reach USD 8,124.35 million by 2034, holding 72% share with a CAGR of 5.71%, driven by widespread adoption in radiology, cardiology, and obstetrics imaging globally.

Top 5 Major Dominant Countries in the Diagnostic Ultrasound Systems Segment

• United States: Diagnostic ultrasound size USD 1,750.60 million by 2034, 21.5% share, growing at 5.63% CAGR, supported by strong healthcare infrastructure and wide cardiology imaging applications.
• Germany: Market expected at USD 820.44 million by 2034, with 10.1% share and a CAGR of 5.58%, driven by advanced radiology and gynecology ultrasound installations.
• China: Diagnostic ultrasound market size USD 1,055.33 million by 2034, capturing 13% share with 5.76% CAGR, fueled by rising demand for maternal and chronic disease diagnostics.
• Japan: Market projected at USD 735.42 million by 2034, achieving 9.1% share with CAGR 5.61%, led by innovation in portable ultrasound and cardiovascular imaging.
• India: Expected size USD 615.12 million by 2034, representing 7.5% share and CAGR 5.84%, supported by government maternal healthcare programs and rural diagnostic expansion.

Therapeutic Ultrasound Systems: Therapeutic ultrasound systems account for nearly 28% of market usage, with rising demand in oncology, physiotherapy, and targeted drug delivery. More than 15% of cancer centers globally adopt therapeutic ultrasound for tumor ablation. Adoption continues growing steadily, with over 10,000 systems installed globally since 2022.

Therapeutic ultrasound systems will achieve USD 3,137.39 million by 2034, with a 28% share and CAGR of 5.32%, expanding primarily in oncology, physiotherapy, and drug delivery applications.

Top 5 Major Dominant Countries in the Therapeutic Ultrasound Systems Segment

• United States: Therapeutic ultrasound size USD 690.25 million by 2034, 22% share, with CAGR 5.29%, boosted by tumor ablation therapies and physiotherapy adoption.
• China: Market to reach USD 525.36 million by 2034, holding 16.7% share and CAGR 5.41%, led by oncology imaging and therapeutic applications.
• Germany: Therapeutic ultrasound size USD 310.65 million by 2034, 9.9% share, with CAGR 5.28%, driven by adoption in chronic pain and physiotherapy treatments.
• Japan: Expected at USD 280.43 million by 2034, representing 8.9% share with CAGR 5.30%, supported by advanced therapeutic ultrasound for oncology care.
• India: Market size USD 240.75 million by 2034, 7.7% share, with CAGR 5.36%, increasing due to expanding cancer treatment centers and physiotherapy facilities.

BY APPLICATION

Radiology/General Imaging: Radiology applications lead with over 30% of global usage, supported by 50 million annual scans worldwide. Hospitals and imaging centers extensively employ ultrasound for liver, kidney, and musculoskeletal imaging, making radiology the largest application segment in terms of adoption and installed base.

Radiology ultrasound will reach USD 3,378.52 million by 2034, securing 30% market share with a CAGR of 5.51%, fueled by chronic disease diagnostics and musculoskeletal imaging worldwide.

Top 5 Major Dominant Countries in Radiology/General Imaging Application

• United States: Radiology ultrasound size USD 880.12 million by 2034, capturing 26% share, with CAGR 5.49%, driven by liver, kidney, musculoskeletal imaging adoption.
• China: Market expected at USD 615.87 million by 2034, securing 18.2% share, CAGR 5.58%, growth supported by high diagnostic imaging demand nationwide.
• Germany: Radiology ultrasound market USD 355.22 million by 2034, accounting for 10.5% share, CAGR 5.47%, primarily adopted in radiology departments across advanced healthcare facilities.
• Japan: Market size USD 320.45 million by 2034, representing 9.5% share, CAGR 5.53%, strongly utilized for preventive care and chronic disease diagnostic imaging.
• India: Radiology ultrasound expected at USD 280.40 million by 2034, holding 8.3% share, CAGR 5.60%, fueled by rural diagnostic expansion and healthcare accessibility.

Obstetrics/Gynecology: Obstetrics/gynecology accounts for 32% of ultrasound demand, with more than 3.6 million pregnancy scans conducted annually in the USA. Globally, the segment continues to expand due to increasing maternal health awareness, prenatal diagnostics, and integration of 3D/4D ultrasound for advanced fetal imaging across hospital networks.

Obstetrics/gynecology ultrasound is projected at USD 3,604.76 million by 2034, representing 32% share, with CAGR of 5.64%, driven by prenatal diagnostics and advanced maternal health imaging globally.

Top 5 Major Dominant Countries in Obstetrics/Gynecology Application

• United States: Obstetrics ultrasound size USD 960.33 million by 2034, 26.6% share, CAGR 5.61%, growth from rising pregnancies and strong 3D/4D imaging adoption.
• China: Market projected at USD 725.12 million by 2034, holding 20.1% share, CAGR 5.70%, supported by high birth rates and improved maternal healthcare.
• India: Obstetrics ultrasound size USD 510.28 million by 2034, representing 14.2% share, CAGR 5.73%, driven by government maternal health initiatives and rising rural access.
• Japan: Market value USD 255.18 million by 2034, 7.1% share, CAGR 5.62%, driven by advanced gynecological imaging systems and rising preventive health awareness.
• Germany: Obstetrics ultrasound projected at USD 230.16 million by 2034, capturing 6.4% share, CAGR 5.59%, primarily fueled by strong prenatal and fetal imaging demand.

Cardiology: Cardiology represents 22% of global ultrasound procedures, driven by high cardiovascular disease prevalence. Over 15 million echocardiography tests annually depend on ultrasound systems, supporting diagnosis of heart disorders, monitoring post-surgery recovery, and improving patient outcomes through advanced real-time Doppler and imaging capabilities worldwide.

Cardiology ultrasound is forecasted to reach USD 2,477.58 million by 2034, representing 22% share, with CAGR of 5.55%, driven by rising cardiovascular disease prevalence globally.

Top 5 Major Dominant Countries in Cardiology Application

• United States: Cardiology ultrasound USD 725.20 million by 2034, holding 29.3% share, CAGR 5.52%, fueled by echocardiography adoption across hospitals and diagnostic centers.
• China: Market projected at USD 490.24 million by 2034, capturing 19.8% share, CAGR 5.59%, driven by cardiovascular disease prevalence and hospital diagnostic growth.
• Germany: Cardiology ultrasound size USD 270.18 million by 2034, with 10.9% share, CAGR 5.54%, used extensively in cardiology-focused healthcare across the nation.
• Japan: Market value USD 255.10 million by 2034, representing 10.3% share, CAGR 5.57%, driven by aging populations needing advanced cardiovascular diagnostic imaging.
• India: Cardiology ultrasound expected at USD 205.12 million by 2034, 8.3% share, CAGR 5.61%, fueled by heart disease cases and urban diagnostic facilities.

Urology: Urology applications hold nearly 10% of market share, with more than 8 million patients annually undergoing ultrasound for kidney stones, prostate evaluation, and urinary disorders. Non-invasive imaging drives strong demand, particularly in elderly populations across developed and emerging regions worldwide.

Urology ultrasound will achieve USD 1,125.88 million by 2034, accounting for 10% share, with CAGR of 5.50%, expanding with urinary and prostate health diagnostics demand.

Top 5 Major Dominant Countries in Urology Application

• United States: Urology ultrasound USD 305.16 million by 2034, with 27% share, CAGR 5.49%, driven by advanced imaging adoption for prostate disorder detection.
• China: Market expected at USD 225.14 million by 2034, 20% share, CAGR 5.55%, fueled by rising kidney disorder prevalence and increased imaging demand.
• Germany: Urology ultrasound size USD 130.11 million by 2034, representing 11.5% share, CAGR 5.47%, supported by healthcare infrastructure and prostate imaging advancements.
• Japan: Market projected at USD 115.16 million by 2034, capturing 10.2% share, CAGR 5.52%, driven by urinary diagnostics in elderly populations nationwide.
• India: Urology ultrasound expected USD 100.20 million by 2034, 8.9% share, CAGR 5.57%, increasing due to expanding urban diagnostic centers and growing urological cases.

Vascular: Vascular ultrasound accounts for 12% of applications, with more than 11 million vascular scans annually. It is extensively used for detecting blood clots, arterial blockages, and circulation disorders, offering clinicians real-time data crucial for diagnosing and managing cardiovascular complications globally.

Vascular ultrasound is expected at USD 1,350.78 million by 2034, securing 12% share, CAGR of 5.56%, driven by demand for circulatory and blood flow imaging.

Top 5 Major Dominant Countries in Vascular Application

• United States: Vascular ultrasound size USD 360.21 million by 2034, with 26.7% share, CAGR 5.54%, primarily applied in cardiovascular diagnostics and hospital imaging.
• China: Market projected at USD 270.13 million by 2034, 20% share, CAGR 5.61%, growing due to vascular disease prevalence and strong diagnostic demand.
• Germany: Vascular ultrasound USD 150.14 million by 2034, capturing 11.1% share, CAGR 5.52%, led by advanced vascular imaging in hospitals and clinics.
• Japan: Market value USD 130.12 million by 2034, representing 9.6% share, CAGR 5.55%, growing with vascular imaging demand among aging populations.
• India: Vascular ultrasound projected USD 115.18 million by 2034, holding 8.5% share, CAGR 5.59%, fueled by cardiovascular disease prevalence in rural and urban regions.

Others: Other applications contribute 8% of global ultrasound usage, covering musculoskeletal, emergency care, and trauma-related imaging. Adoption is rising, especially in sports medicine and point-of-care diagnostics, with growing utilization of portable ultrasound systems across over 500 clinics in Asia-Pacific since 2023.

Other ultrasound applications will reach USD 674.07 million by 2034, representing 6% share, with CAGR of 5.45%, including musculoskeletal, emergency, and trauma imaging worldwide.

Top 5 Major Dominant Countries in Other Applications

• United States: Other ultrasound applications USD 180.14 million by 2034, holding 26.7% share, CAGR 5.44%, widely used in trauma, emergency, and sports medicine.
• China: Market expected USD 140.10 million by 2034, capturing 20.7% share, CAGR 5.48%, driven by emergency ultrasound adoption across hospitals and clinics.
• Germany: Other ultrasound applications size USD 75.12 million by 2034, 11.1% share, CAGR 5.42%, supported by musculoskeletal and orthopedic ultrasound expansion.
• Japan: Market projected USD 70.08 million by 2034, representing 10.4% share, CAGR 5.45%, boosted by portable ultrasound systems in diagnostic practices.
• India: Other ultrasound applications expected USD 60.13 million by 2034, 8.9% share, CAGR 5.47%, increasing due to rural trauma and emergency healthcare adoption.

Medical Ultrasound Devices Market Regional Outlook

The medical ultrasound devices market shows strong regional variations, with North America leading in advanced technology adoption, Europe prioritizing prenatal and chronic disease diagnostics, Asia-Pacific driving installations, and Middle East & Africa expanding maternal and cardiovascular imaging access rapidly.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

NORTH AMERICA

North America holds around 37% of the global market share, with over 60,000 ultrasound systems installed across the USA and Canada. Advanced adoption of portable devices and strong investments in cardiology and obstetrics imaging drive growth. High procedure volumes across 6,000+ hospitals highlight significant reliance on ultrasound imaging technologies.

North America will reach USD 4,165.34 million by 2034, capturing 37% share, CAGR 5.57%, driven by high adoption in diagnostic ultrasound, cardiology, and obstetrics imaging applications.

North America – Major Dominant Countries in the Medical Ultrasound Devices Market

• United States: Market size USD 3,215.12 million by 2034, holding 27.7% share, CAGR 5.56%, driven by widespread diagnostic ultrasound demand in hospitals and advanced cardiology applications.
• Canada: Market value USD 450.18 million by 2034, with 3.9% share, CAGR 5.54%, driven by rising prenatal care ultrasound adoption and advanced imaging infrastructure.
• Mexico: Ultrasound market USD 320.10 million by 2034, capturing 2.7% share, CAGR 5.57%, supported by portable ultrasound demand across rural healthcare and emergency departments.
• Cuba: Market expected at USD 105.12 million by 2034, 0.9% share, CAGR 5.53%, growth from government healthcare initiatives boosting ultrasound accessibility.
• Puerto Rico: Ultrasound devices size USD 75.11 million by 2034, 0.6% share, CAGR 5.55%, fueled by expanding maternal health ultrasound services and diagnostic imaging.

EUROPE

Europe accounts for nearly 28% of the global market share, supported by more than 70 million ultrasound scans annually. Germany, France, and the UK are leading adopters, focusing on chronic disease management and prenatal care. Widespread usage of 3D and 4D ultrasound systems in gynecology continues to expand across the region.

Europe is projected at USD 3,153.30 million by 2034, representing 28% share, CAGR 5.58%, driven by strong adoption in radiology, gynecology, and cardiovascular ultrasound procedures.

Europe – Major Dominant Countries in the Medical Ultrasound Devices Market

• Germany: Market size USD 990.20 million by 2034, with 8.8% share, CAGR 5.57%, driven by high demand in prenatal ultrasound and advanced radiology imaging facilities.
• France: Market expected at USD 725.14 million by 2034, 6.4% share, CAGR 5.59%, supported by expanding cardiovascular ultrasound procedures and government healthcare programs.
• United Kingdom: Ultrasound devices size USD 660.12 million by 2034, holding 5.8% share, CAGR 5.56%, driven by general imaging, gynecology, and emergency ultrasound expansion.
• Italy: Market projected at USD 435.13 million by 2034, with 3.8% share, CAGR 5.55%, growth supported by rising radiology ultrasound demand nationwide.
• Spain: Market size USD 343.11 million by 2034, 3% share, CAGR 5.54%, fueled by strong point-of-care ultrasound adoption in hospitals and emergency care.

ASIA-PACIFIC

Asia-Pacific contributes approximately 24% of the market, driven by China’s strong production capacity and India’s 12,000+ annual ultrasound installations. Japan and South Korea also play key roles in innovation. Rising healthcare investments, growing maternal health programs, and portable ultrasound adoption in rural areas boost ultrasound market expansion in this region.

Asia-Pacific will reach USD 2,702.81 million by 2034, capturing 24% share, CAGR 5.61%, led by China, India, and Japan with growing maternal and cardiovascular ultrasound applications.

Asia-Pacific – Major Dominant Countries in the Medical Ultrasound Devices Market

• China: Market size USD 1,580.20 million by 2034, holding 14% share, CAGR 5.63%, fueled by diagnostic ultrasound adoption in maternal healthcare and chronic disease management.
• India: Ultrasound market USD 895.14 million by 2034, representing 7.8% share, CAGR 5.64%, driven by government maternal programs and rural healthcare ultrasound expansion.
• Japan: Market expected USD 785.15 million by 2034, 6.9% share, CAGR 5.59%, supported by aging population and strong adoption of portable diagnostic ultrasound devices.
• South Korea: Ultrasound devices size USD 295.12 million by 2034, 2.6% share, CAGR 5.61%, growth from advanced ultrasound research, development, and technological innovation.
• Australia: Market projected at USD 245.10 million by 2034, holding 2.1% share, CAGR 5.58%, driven by radiology ultrasound adoption and cardiovascular imaging procedures.

MIDDLE EAST & AFRICA

The Middle East & Africa represent around 11% of the global market share, with GCC nations and South Africa leading adoption. Over 7,000 ultrasound units are installed annually, primarily for maternal health and cardiovascular imaging. Expanding government healthcare programs and demand for point-of-care ultrasound drive significant regional growth.

Middle East & Africa will achieve USD 1,240.98 million by 2034, securing 11% share, CAGR 5.53%, driven by maternal health, cardiovascular diagnostics, and portable ultrasound growth.

Middle East and Africa – Major Dominant Countries in the Medical Ultrasound Devices Market

• Saudi Arabia: Market size USD 365.12 million by 2034, with 3.2% share, CAGR 5.52%, supported by advanced healthcare spending and strong prenatal ultrasound adoption.
• United Arab Emirates: Ultrasound market USD 225.14 million by 2034, representing 2% share, CAGR 5.55%, fueled by maternal ultrasound programs and cardiovascular diagnostic expansion.
• South Africa: Market expected at USD 210.15 million by 2034, capturing 1.8% share, CAGR 5.54%, driven by oncology and therapeutic ultrasound adoption.
• Egypt: Ultrasound devices size USD 170.11 million by 2034, 1.5% share, CAGR 5.52%, supported by expanding maternal and gynecology ultrasound programs.
• Nigeria: Market projected at USD 120.10 million by 2034, 1% share, CAGR 5.53%, fueled by strong demand for portable ultrasound in rural healthcare.

List of Top Medical Ultrasound Devices Companies

• Samsung Medison Co., Ltd.
• GE Healthcare
• BK Medical APS
• Hitachi Healthcare Manufacturing, Ltd.
• Canon Medical Systems Corporation
• FUJIFILM SonoSite, Inc.
• Mindray Medical International Limited.
• Siemens Healthineers
• Misonix, Inc.
• Esaote SPA
• Philips Healthcare

Top Two Companies with Highest Market Share:

• GE Healthcare: GE Healthcare holds nearly 19% of global market share, with widespread adoption of its diagnostic ultrasound systems across more than 100 countries.
• Siemens Healthineers: Siemens Healthineers accounts for approximately 17% of the global share, with over 45,000 ultrasound systems installed worldwide.

Investment Analysis and Opportunities

The medical ultrasound devices market presents strong investment potential across diagnostic and therapeutic segments. More than $5 billion has been allocated globally by governments and healthcare organizations for diagnostic imaging infrastructure since 2023, resulting in expanded ultrasound adoption. Investors are increasingly focusing on portable ultrasound technologies, with handheld devices representing over 25% of new market entries between 2022 and 2025.

Private sector investment has fueled innovation, with over 60% of ultrasound start-ups since 2023 focusing on AI-powered solutions. The expansion of healthcare facilities in Asia-Pacific creates opportunities, as India and China collectively install more than 20,000 ultrasound units annually. Emerging markets in Africa also provide opportunities, with the demand for prenatal ultrasound increasing by 30% annually. Investments in R&D are also significant, with leading companies dedicating over 12% of annual budgets toward ultrasound innovation.

New Product Development

New product development is reshaping the medical ultrasound devices industry. Between 2023 and 2025, more than 47% of new ultrasound launches incorporated portable designs. GE Healthcare recently launched compact handheld devices that deliver high-resolution imaging and AI-powered analysis, while Philips introduced ultrasound platforms integrated with telemedicine solutions, allowing real-time remote diagnostics.

AI-based imaging platforms are becoming dominant, with over 55% of high-end systems launched post-2023 including AI-assisted diagnostic features. Manufacturers are also focusing on enhancing 3D and 4D imaging capabilities, which are now used in over 65% of obstetric procedures globally. Recent innovations include battery-operated systems with over 8 hours of runtime, improving accessibility in rural regions.

Five Recent Developments

• In 2023, Philips launched a handheld ultrasound device with real-time AI image optimization.
• In 2024, GE Healthcare introduced an advanced echocardiography platform used in over 200 hospitals within six months.
• In 2024, Siemens Healthineers integrated cloud-based ultrasound data storage across 1,000 hospitals globally.
• In 2025, Mindray launched portable ultrasound systems for rural healthcare, adopted by over 500 clinics in Asia-Pacific.
• In 2025, Samsung Medison released 4D fetal imaging ultrasound platforms, performing over 2 million scans within the first year.

Report Coverage of Medical Ultrasound Devices Market

The medical ultrasound devices market report provides a comprehensive analysis of technological advancements, competitive landscapes, and adoption patterns across multiple regions. The report includes segmentation by type, with diagnostic ultrasound systems accounting for over 72% of usage, and therapeutic ultrasound systems representing the rest. By application, obstetrics/gynecology holds 32% share, cardiology accounts for 22%, and radiology/general imaging leads with 30%.

Regional coverage highlights North America’s 37% global market share, Europe’s 28%, Asia-Pacific’s 24%, and Middle East & Africa’s 11%. The report outlines company performance, with GE Healthcare and Siemens Healthineers together contributing 36% share of global installations. Coverage also extends to recent developments, with over 47% of innovations between 2023 and 2025 focused on portable ultrasound systems.

The report includes detailed insights into market drivers such as rising chronic disease prevalence, restraints like high system costs, opportunities in portable ultrasound adoption, and challenges related to workforce shortages. It further highlights investments, product development, and emerging trends, providing a holistic view of the industry’s growth trajectory.

Medical Ultrasound Devices Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 7285.95 Million in 2026
Market Size Value By	USD 11891.27 Million by 2035
Growth Rate	CAGR of 5.59% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Diagnostic Ultrasound Systems Therapeutic Ultrasound Systems By Application : Radiology/General Imaging Obstetrics/Gynecology Cardiology Urology Vascular Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample